Literature DB >> 16424054

Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity.

Jun-Eui Park1, John Facciponte, Xing Chen, Ian MacDonald, Elizabeth A Repasky, Masoud H Manjili, Xiang-Yang Wang, John R Subjeck.   

Abstract

When used as vaccines, tumor-derived stress proteins can elicit antitumor immune responses. For members of the hsp70 superfamily, like grp170, this seems to be due to (a) the chaperoning of antigenic peptide by the stress protein and (b) the binding of the stress protein to receptor(s) on antigen-presenting cells (APC) and subsequent antigen presentation. This suggests that domains exist on the stress protein for each function. In this study, we determine the ability of grp170 and its structural domains to (a) bind to and present melanoma-associated antigen gp100 to the immune system and (b) to bind to receptors on APCs. A direct correlation between chaperone function, binding to APCs in a receptor-like manner, and antitumor immunity was observed. Two mutants that share no common sequence, yet are both effective in their antitumor activities, compete with one another for APC binding. Studies of other members of the hsp70 superfamily, hsp110 and hsp70, or their domain deletion mutants, further confirmed that APC binding segregates with chaperoning function and not sequence. Therefore, these studies suggest that molecular chaperoning is involved in stress protein interactions with APCs, antigen binding, and in eliciting antitumor immunity, thus bridging this ancient function of stress proteins in prokaryotes to their ability to elicit immunity in higher organisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424054     DOI: 10.1158/0008-5472.CAN-05-2609

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma.

Authors:  Jie Qian; Huanfa Yi; Chunqing Guo; Xiaofei Yu; Daming Zuo; Xing Chen; John M Kane; Elizabeth A Repasky; John R Subjeck; Xiang-Yang Wang
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

2.  Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy.

Authors:  Chunqing Guo; John R Subjeck; Xiang-Yang Wang
Journal:  Methods Mol Biol       Date:  2018

3.  Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity.

Authors:  Daming Zuo; Xiaofei Yu; Chunqing Guo; Huanfa Yi; Xing Chen; Daniel H Conrad; Tai L Guo; Zhengliang Chen; Paul B Fisher; John R Subjeck; Xiang-Yang Wang
Journal:  FASEB J       Date:  2011-12-29       Impact factor: 5.191

4.  Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo.

Authors:  Hilal Arnouk; Evan R Zynda; Xiang-Yang Wang; Bonnie L Hylander; Masoud H Manjili; Elizabeth A Repasky; John R Subjeck; A Latif Kazim
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

5.  Endoplasmic reticulum retention signal-dependent glycylation of the Hsp70/Grp170-related Pgp1p in Tetrahymena.

Authors:  Rong Xie; Kathleen M Clark; Martin A Gorovsky
Journal:  Eukaryot Cell       Date:  2006-12-22

Review 6.  High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy.

Authors:  Xiang-Yang Wang; John R Subjeck
Journal:  Int J Hyperthermia       Date:  2013-07-05       Impact factor: 3.914

Review 7.  The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells.

Authors:  Mathias Gehrmann; Jürgen Radons; Michael Molls; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2008-02-05       Impact factor: 3.667

8.  High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK.

Authors:  Volker Burkart; Rahel K Siegenthaler; Elias Blasius; Koen Vandenbroeck; Iraide Alloza; Waltraud Fingberg; Nanette C Schloot; Philipp Christen; Hubert Kolb
Journal:  BMC Biochem       Date:  2010-11-08       Impact factor: 4.059

9.  A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.

Authors:  Xiaofei Yu; Chunqing Guo; Huanfa Yi; Jie Qian; Paul B Fisher; John R Subjeck; Xiang-Yang Wang
Journal:  Cancer Res       Date:  2013-01-18       Impact factor: 12.701

10.  Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24.

Authors:  Ping Gao; Xiaolei Sun; Xing Chen; Yanping Wang; Barbara A Foster; John Subjeck; Paul B Fisher; Xiang-Yang Wang
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.